ACCORDs

Linkedin

Main objectives

To develop purpose-oriented correlative approaches for the characterization and quantification of 2D nanomaterials as produced and in complex matrices and determination of their transformations in such environments.

To increase the availability of validated protocols to advance both nanosafety studies and material characterisation and deliver improved data reporting guidelines.

To ensure appropriate, realistic in vitro models to address current gaps in nanotoxicology.
To deliver reliable data to support computational modelling and the development of grouping and read-across methods.

To develop harmonised standard operating procedures (SOPs) that can be used in a regulatory framework, including test hazard assessment, biodegradability, and sustainability for advanced 2D nanomaterials.

Worldwide accepted risk assessment tools for establishing a robust supply chain for GFMs.

This project receives funding from the European Union’s Horizon Europe Research & Innovation Programme under grant agreement no. 101092796.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

Associated Partners (i.e. (a) Swiss Partners and (b) UK Partners) have received national funding from (a) the Swiss State Secretariat for Education, Research and Innovation (SERI), and (b) Innovate UK. 

ACCORDs

Explore

Privacy

copyright © 2024 ACCORDs All right reserved
Website Created by Distrito Federal Media

ACCORDs

This website uses its own cookies for its proper functioning. By clicking the Accept button, you agree to the use of these technologies and the processing of your data for these purposes.   
Privacidad